Cite
MLA Citation
U Kopylov et al.. “DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study.” Journal of Crohn's and colitis, vol. 12, n.d., pp. S029–S030. http://access.bl.uk/ark:/81055/vdc_100095513553.0x00000e